顺铂
缺氧(环境)
纳米医学
癌症研究
DNA损伤
DNA修复
细胞内
DNA
医学
化疗
化学
生物
细胞生物学
内科学
遗传学
纳米技术
材料科学
氧气
纳米颗粒
有机化学
作者
Jing Chen,Xue Wang,Yuan Yuan,Haoting Chen,Lingpu Zhang,Haihua Xiao,Jingqi Chen,Yongxiang Zhao,Jin Keun Chang,Weisheng Guo,Xing‐Jie Liang
出处
期刊:Science Advances
[American Association for the Advancement of Science]
日期:2021-03-26
卷期号:7 (13): eabc5267-
被引量:92
标识
DOI:10.1126/sciadv.abc5267
摘要
Various cancers treated with cisplatin almost invariably develop drug resistance that is frequently caused by substantial DNA repair. We searched for acquired vulnerabilities of cisplatin-resistant cancers to identify undiscovered therapy. We herein found that cisplatin resistance of cancer cells comes at a fitness cost of increased intracellular hypoxia. Then, we conceived an inspired strategy to combat the tumor drug resistance by exploiting the increased intracellular hypoxia that occurs as the cells develop drug resistance. Here, we constructed a hypoxia-amplifying DNA repair-inhibiting liposomal nanomedicine (denoted as HYDRI NM), which is formulated from a platinum(IV) prodrug as a building block and payloads of glucose oxidase (GOx) and hypoxia-activatable tirapazamine (TPZ). In studies on clinically relevant models, including patient-derived organoids and patient-derived xenograft tumors, the HYDRI NM is able to effectively suppress the growth of cisplatin-resistant tumors. Thus, this study provides clinical proof of concept for the therapy identified here.
科研通智能强力驱动
Strongly Powered by AbleSci AI